8-K
PRO-PHARMACEUTICALS, INC. 8-K
- Company
- GALECTIN THERAPEUTICS INC
- Filed
- April 17, 2007
- Period of Report
- April 17, 2007
- Accession Number
- 0001157523-07-003641
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →